Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Clene Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −1 vs. Q3 2022
- Shares held
- 3.08M
- −1.13M (−26.8%) vs. Q3 2022
- Total value
- $3.09M
- −$8.68M (−73.8%) vs. Q3 2022
- New holders
- 9
- 8 more added
- Sold out
- 10
- 8 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $19.6M |
| Q1 2026 | 29 | $10.8M |
| Q4 2025 | 28 | $11.4M |
| Q3 2025 | 29 | $4.72M |
| Q2 2025 | 24 | $2.28M |
| Q1 2025 | 24 | $1.40M |
| Q4 2024 | 27 | $2.60M |
| Q3 2024 | 20 | $4.66M |
| Q2 2024 | 37 | $2.40M |
| Q1 2024 | 44 | $3.10M |
| Q4 2023 | 46 | $3.50M |
| Q3 2023 | 47 | $12.3M |
| Q2 2023 | 50 | $28.1M |
| Q1 2023 | 31 | $3.42M |
| Q4 2022 | 35 | $3.09M |
| Q3 2022 | 38 | $12.1M |
| Q2 2022 | 42 | $8.93M |
| Q1 2022 | 53 | $24.7M |
| Q4 2021 | 48 | $26.0M |
| Q3 2021 | 39 | $37.8M |
| Q2 2021 | 35 | $51.6M |
| Q1 2021 | 24 | $31.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Clene Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 932,058 | $932.1K | 0.00% | +4450.0% | Added |
| Kepos Capital LP | 344,427 | $344.0K | 0.05% | −55,573−13.9% | Reduced |
| Laird Norton Trust Company, LLC | 268,581 | $268.6K | 0.04% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 230,805 | $230.0K | 0.00% | +9,614+4.3% | Added |
| Soltis Investment Advisors LLC | 218,920 | $218.9K | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 185,245 | $185.2K | 0.00% | +1,244+0.7% | Added |
| Group One Trading, L.P. | 126,340 | $126.3K | 0.00% | +126,340 | New |
| Atom Investors LP | 123,051 | $123.1K | 0.06% | +123,051 | New |
| Millennium Management LLC | 117,137 | $117.0K | 0.00% | −92,947−44.2% | Reduced |
| Bridgeway Capital Management, LLC | 100,774 | $100.8K | 0.00% | +100,774 | New |
| Simplex Trading, LLC | 92,290 | $92.0K | 0.00% | −40,125−30.3% | Reduced |
| State Street Corp | 68,046 | $68.0K | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 55,250 | $55.3K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 37,172 | $37.2K | 0.00% | 00.0% | Unchanged |
| Belvedere Trading LLC | 27,295 | $27.3K | 0.02% | +27,295 | New |
| Pallas Capital Advisors LLC | 17,341 | $25.8K | 0.00% | 00.0% | Unchanged |
| Veritable, L.P. | 25,230 | $25.2K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 23,099 | $23.1K | 0.00% | +23,099 | New |
| Morgan Stanley | 16,744 | $16.7K | 0.00% | +3,399+25.5% | Added |
| Susquehanna International Group, LLP | 13,000 | $13.0K | 0.00% | +13,000 | New |
| Two Sigma Investments, LP | 11,970 | $12.0K | 0.00% | −21,429−64.2% | Reduced |
| UBS Group AG | 9,712 | $9.71K | 0.00% | +3,230+49.8% | Added |
| Tower Research Capital LLC (TRC) | 9,336 | $9.00K | 0.00% | −5,042−35.1% | Reduced |
| Bank of America Corp | 6,878 | $6.88K | 0.00% | +30+0.4% | Added |
| Advisor Group Holdings, Inc. | 5,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 5,200 | $5.00K | 0.01% | +5,200 | New |
| Cutler Group LP | 4,200 | $4.00K | 0.00% | +2,600+162.5% | Added |
| Citadel Advisors LLC | 3,451 | $3.45K | 0.00% | −33,018−90.5% | Reduced |
| Washington Trust Co | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 400 | $400 | 0.00% | −440−52.4% | Reduced |
| Steward Partners Investment Advisory, LLC | 300 | $300 | 0.00% | +300 | New |
| Wells Fargo & Company | 211 | $211 | 0.00% | +77+57.5% | Added |
| Barclays PLC | 140 | $140 | 0.00% | −510−78.5% | Reduced |
| Citigroup Inc | 100 | $100 | 0.00% | +100 | New |
| JPMorgan Chase & Co | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −1,100,000−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −81,718−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −52,017−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −29,526−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −20,749−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −19,140−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,944−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −2,740−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −247−100.0% | Sold out |
| Morgan Jess S & Co Inc | – | – | – | – | Not filed |
| Jefferies Group LLC | – | – | – | – | Not filed |